Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver
Open accessThe DOI matches its OpenAlex record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The physiological relevance of phosphoinositide 3-kinase (PI 3-K) signaling in the liver to fuel homeostasis was investigated. Systemic infusion of an adenovirus encoding a dominant negative mutant of PI 3-K ((Delta)p85) resulted in liver-specific expression of this protein and in inhibition of the insulin-induced activation of PI 3-K in the liver within 3 days, without affecting insulin signaling in skeletal muscle. Hepatic expression of (Delta)p85 led to hyperinsulinemia and to a marked increase in blood glucose concentration in response to oral glucose intake. The increases in both glycogen and glucose 6-phosphate content, as well as in Akt and glycogen synthase activities in the liver, that were induced by glucose intake were markedly impaired in mice expressing (Delta)p85. Despite an upregulation of mRNAs for gluconeogenic enzymes apparent in the liver of these animals, the fasting blood glucose concentration was increased only slightly, and the serum concentrations of gluconeogenic precursors were reduced. However, administration of pyruvate, a substrate for gluconeogenesis, resulted in an exaggerated increase in blood glucose concentration. In the fasted state, the mass of adipose tissue of the mice was about 1.5 times that in control mice. The mice also exhibited marked decreases in the serum concentrations of FFAs and triglyceride and suppression of insulin-induced PI 3-K activation in adipose tissue, probably due to the associated hyperinsulinemia. PI 3-K activity in the liver is thus essential for normal carbohydrate and lipid metabolism in living animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 1×
“Phosphorylation of Akt and that of GSK3, both of which are thought to contribute to the activation of glycogen synthase (20, 33), were stimulated in the liver of LacZ mice by glucose intake (Figure 4h).”
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252 · cited 1×
“However, heterozygous knockout of the IRS-1 gene, which resulted in an approximately 50% decrease in the abundance of IRS-1 protein throughout the body, did not induce marked changes in metabolic parameters (40, 41), suggesting that the metabolic characteristics of DNPI3K mice are dependent on the inhibition of PI 3-K…”
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953 · cited 8×
“Introduction Among the various signaling molecules activated by insulin, a number of in vitro studies indicate that the class IA phosphoinositide 3-kinase (PI 3-K), which consists of a 110-kDa catalytic subunit and an Src homology 2 domain–containing regulatory subunit, plays a key role in the metabolic actions of thi…”
InfluentialKim, Y.-B., Nikoulina, S. E., Ciaraldi, T. P., Henry, R. R., & Kahn, B. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6928 · Cited by 487
Terauchi, Y., Tsuji, Y., Satoh, S., Minoura, H., Murakami, K., Okuno, A., Inukai, K., Asano, T., Kaburagi, Y., Ueki, K., et al. (1999) · Nature Genetics · doi:10.1038/6023 · Cited by 399
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis.
Radziuk, J., & Pye, S. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.217 · Cited by 267 · cited 2×
“Conversion of glucose to glucose 6-phosphate, catalyzed by gluco-kinase, is the initial step of glucose utilization, and the opposite reaction, catalyzed by glucose-6-phosphatase, is the final step of glucose production in the liver (36).”
Mauvais-Jarvis, F., Ueki, K., Fruman, D. A., Hirshman, M. F., Sakamoto, K., Goodyear, L. J., Iannacone, M., Accili, D., Cantley, L. C., & Kahn, C. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213305 · Cited by 207
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
Kim, J. K., Zisman, A., Fillmore, J. J., Peroni, O. D., Kotani, K., Perret, P., Zong, H., Dong, J., Kahn, C. R., Kahn, B. B., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10294 · Cited by 202 · cited 1×
“Although several mouse models have been established that lack a specific protein in a specific tissue, these models have still exhibited abnormalities in multiple organs, probably due to secondary effects of chronic metabolic alterations (15, 16).”
Tsuchida, A., Nakagawa, T., Itakura, Y., Ichihara, J., Ogawa, W., Kasuga, M., Taiji, M., & Noguchi, H. (2001) · Diabetologia · doi:10.1007/s001250051661 · Cited by 91
Self-citation
Research works printed but not linked: 30
- 10.1023/A:1006862807598 · DOI
- 10.1210/me.11.10.1552 · DOI · Paper page
- Kitamura, 1999, Mol Cell Biol, 19, 6286, 10.1128/MCB.19.9.6286 · DOI · Paper page
- 10.1074/jbc.274.30.21305 · DOI · Paper page
- 10.2337/diabetes.51.6.1672 · DOI · Paper page
- 10.1172/JCI116337 · DOI · Paper page
- 10.1074/jbc.274.16.10963 · DOI · Paper page
- 10.1038/81715 · DOI · Paper page
- 10.1073/pnas.012581799 · DOI · Paper page
- 10.1038/35055575 · DOI · Paper page
- 10.1073/pnas.91.16.7415 · DOI · Paper page
- 10.1074/jbc.274.29.20611 · DOI · Paper page
- DiTullio, 1974, Biochem J, 138, 387, 10.1042/bj1380387 · DOI · Paper page
- 10.1016/0047-6374(94)90030-2 · DOI
- 10.1016/0040-4039(96)00661-2 · doi:10.1016/0040-4039(96)00661-2
- Matsuda, 1990, J Biochem (Tokyo), 108, 778, 10.1093/oxfordjournals.jbchem.a123280 · DOI
- 10.1172/JCI118951 · DOI · Paper page
- Beale, 1985, J Biol Chem, 260, 10748, 10.1016/S0021-9258(19)85145-1 · DOI · Paper page
- Shingu, 1996, Res Commun Mol Pathol Pharmacol, 93, 13
- 10.1038/ng0892-372 · DOI · Paper page
- 10.1074/jbc.273.47.31615 · DOI · Paper page
- 10.1042/0264-6021:3500389 · doi:10.1042/0264-6021:3500389
- 10.1074/jbc.273.32.20144 · DOI · Paper page
- Flaim, 1985, Am J Physiol, 249, E447, 10.1152/ajpcell.1985.249.5.C447 · doi:10.1152/ajpcell.1985.249.5.c447
- DeFronzo, 1997, Diabetes Rev, 5, 177
- 10.1016/S1097-2765(00)00010-1 · DOI · Paper page
- 10.1079/BJN19970105 · DOI · Paper page
- Oliver, 1993, Biochem J, 292, 525, 10.1042/bj2920525 · doi:10.1042/bj2920525
- Fisher, 2001, Diabetes, 50(Suppl. 2), A50
- 10.1038/372182a0 · DOI · Paper page
Cited by
Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396
“To further examine the role of Adipor1 or Adipor2 in the regulation of gluconeogenesis, we performed a pyruvate challenge tes”
MethodDefects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Rudic, R. D., McNamara, P., Curtis, A.-M., Boston, R. C., Panda, S., Hogenesch, J. B., & FitzGerald, G. A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020377 · Cited by 1,059
“Consistent with this observation, conversion of exogenously administered pyruvate to glucose, which reflects gluconeogenesis (Miyake et al. 2002), was impaired in the Clockmut animals.”
BackgroundBasic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Metadata
- Authors
- Miyake, K., Ogawa, W., Matsumoto, M., Nakamura, T., Sakaue, H., & Kasuga, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-11-15
- Volume
- 110
- Issue
- 10
- Pages
- 1483-1491
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2085039511
- Cited by
- 147
- References
- 9
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.